Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MASI Stock Forecast 2025-2026
$143.16
Current Price
$7.78B
Market Cap
Buy 6
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to MASI Price Targets
+46.7%
To High Target of $210.00
+29.2%
To Median Target of $185.00
+17.4%
To Low Target of $168.00
MASI Price Momentum
+1.8%
1 Week Change
-4.9%
1 Month Change
-11.9%
1 Year Change
-13.4%
Year-to-Date Change
-26.5%
From 52W High of $194.88
+7.1%
From 52W Low of $133.70
📊 TOP ANALYST CALLS
Did MASI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Masimo is one of their latest high-conviction picks.
Latest MASI Stock Price Targets & Analyst Predictions
Based on our analysis of 12 Wall Street analysts, MASI has a bullish consensus with a median price target of $185.00 (ranging from $168.00 to $210.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $143.16, the median forecast implies a 29.2% upside. This outlook is supported by 6 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Jason Bednar at Piper Sandler, projecting a 46.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MASI Analyst Ratings
6
Buy
2
Hold
0
Sell
MASI Price Target Range
Low
$168.00
Average
$185.00
High
$210.00
Current: $143.16
Latest MASI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MASI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 5, 2025 | Wells Fargo | Vik Chopra | Overweight | Maintains | $187.00 |
| Nov 5, 2025 | BTIG | Marie Thibault | Buy | Reiterates | $198.00 |
| Sep 11, 2025 | BTIG | Marie Thibault | Buy | Reiterates | $198.00 |
| Aug 6, 2025 | Piper Sandler | Jason Bednar | Overweight | Maintains | $210.00 |
| May 7, 2025 | Piper Sandler | Jason Bednar | Overweight | Reiterates | $200.00 |
| May 7, 2025 | Wells Fargo | Vik Chopra | Overweight | Maintains | $190.00 |
| May 7, 2025 | Raymond James | Jayson Bedford | Outperform | Maintains | $185.00 |
| Apr 10, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Feb 26, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Feb 26, 2025 | Piper Sandler | Jason Bednar | Overweight | Maintains | $215.00 |
| Feb 26, 2025 | Wells Fargo | Vik Chopra | Overweight | Maintains | $205.00 |
| Jan 22, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Jan 16, 2025 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Dec 27, 2024 | Raymond James | Jayson Bedford | Outperform | Maintains | $194.00 |
| Dec 18, 2024 | Piper Sandler | Jason Bednar | Overweight | Maintains | $210.00 |
| Dec 11, 2024 | Wells Fargo | Vik Chopra | Overweight | Maintains | $193.00 |
| Nov 22, 2024 | Stifel | Rick Wise | Buy | Reiterates | $190.00 |
| Nov 6, 2024 | Needham | Mike Matson | Hold | Reiterates | $N/A |
| Nov 6, 2024 | Wells Fargo | Vik Chopra | Overweight | Maintains | $171.00 |
| Nov 6, 2024 | Raymond James | Jayson Bedford | Outperform | Upgrade | $170.00 |
Masimo Corporation (MASI) Competitors
The following stocks are similar to Masimo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Masimo Corporation (MASI) Financial Data
Masimo Corporation has a market capitalization of $7.78B with a P/E ratio of 129.2x. The company generates $2.18B in trailing twelve-month revenue with a -26.1% profit margin.
Revenue growth is +8.2% quarter-over-quarter, while maintaining an operating margin of +22.5% and return on equity of -21.1%.
Valuation Metrics
Market Cap
$7.78B
Enterprise Value
$7.96B
P/E Ratio
129.2x
PEG Ratio
0.6x
Price/Sales
3.5x
Growth & Margins
Revenue Growth (YoY)
+8.2%
Gross Margin
+62.9%
Operating Margin
+22.5%
Net Margin
-26.1%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+4.1%
Current Ratio
2.8x
Debt/Equity
72.4x
ROE
-21.1%
ROA
+3.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Masimo Corporation (MASI) Business Model
About Masimo Corporation
What They Do
Develops noninvasive medical monitoring technologies.
Business Model
Masimo Corporation generates revenue by designing and manufacturing advanced medical devices, particularly pulse oximetry systems that provide noninvasive measurements of vital signs. The company's products are utilized in various healthcare environments, allowing for better patient monitoring and clinical decision-making, thus enhancing both patient outcomes and healthcare efficiency.
Additional Information
The company, based in Irvine, California, is recognized for the precision and reliability of its technologies, even in challenging clinical conditions. Masimo is focused on continuous innovation and expanding its range of health monitoring solutions, influencing multiple sectors within the healthcare industry, including emergency and critical care.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
3,600
CEO
Ms. Catherine M. Szyman
Country
United States
IPO Year
2007
Website
www.masimo.comMasimo Corporation (MASI) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Masimo (MASI) Q3 Earnings and Revenues Top Estimates
Masimo (MASI) delivered earnings and revenue surprises of +10.92% and +1.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 04, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Masimo exceeded Q3 2025 earnings and revenue forecasts, benefiting from improved operating margins and profits due to reduced expenses.
Why It Matters
Masimo's strong Q3 2025 performance, with higher earnings and improved margins due to reduced expenses, signals financial health and potential for future growth, boosting investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores help investors identify top-rated stocks tailored to their investing style, providing a useful tool for stock selection.
Why It Matters
Zacks Style Scores can help investors identify high-potential stocks aligned with their strategies, enhancing portfolio performance and investment decision-making.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Masimo (MASI) has been upgraded to a Zacks Rank #2 (Buy), indicating increased optimism about its earnings, potentially boosting the stock price in the near term.
Why It Matters
Masimo's Zacks Rank upgrade signals improved earnings expectations, likely boosting investor confidence and potentially increasing stock value in the near term.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Masimo (MASI) has strong growth attributes that may enable it to outperform the market.
Why It Matters
Masimo's strong growth potential suggests it may deliver higher returns than the broader market, attracting investors seeking opportunities for capital appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Masimo Corporation (MASI) will hold its Q3 2025 Earnings Call on November 4, 2025, at 4:30 PM EST. The call will feature key company executives and analysts from various firms.
Why It Matters
Masimo's Q3 earnings call will reveal financial performance and strategic updates, crucial for assessing growth potential and market positioning, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Masimo Reports Third Quarter 2025 Results
4 days ago
Quick Summary
Masimo Corporation reported Q3 2025 GAAP revenue of $371.5 million (8.2% growth) and non-GAAP revenue of $371.2 million (7.6% growth). GAAP net income per share was $0.99; non-GAAP was $1.32.
Why It Matters
Masimo's Q3 2025 results show solid revenue growth and strong earnings per share, indicating operational strength and potential for continued profitability, influencing investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About MASI Stock
What is Masimo Corporation's (MASI) stock forecast for 2026?
Based on our analysis of 12 Wall Street analysts, Masimo Corporation (MASI) has a median price target of $185.00. The highest price target is $210.00 and the lowest is $168.00.
Is MASI stock a good investment in 2026?
According to current analyst ratings, MASI has 6 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $143.16. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MASI stock?
Wall Street analysts predict MASI stock could reach $185.00 in the next 12 months. This represents a 29.2% increase from the current price of $143.16. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Masimo Corporation's business model?
Masimo Corporation generates revenue by designing and manufacturing advanced medical devices, particularly pulse oximetry systems that provide noninvasive measurements of vital signs. The company's products are utilized in various healthcare environments, allowing for better patient monitoring and clinical decision-making, thus enhancing both patient outcomes and healthcare efficiency.
What is the highest forecasted price for MASI Masimo Corporation?
The highest price target for MASI is $210.00 from Jason Bednar at Piper Sandler, which represents a 46.7% increase from the current price of $143.16.
What is the lowest forecasted price for MASI Masimo Corporation?
The lowest price target for MASI is $168.00 from at , which represents a 17.4% increase from the current price of $143.16.
What is the overall MASI consensus from analysts for Masimo Corporation?
The overall analyst consensus for MASI is bullish. Out of 12 Wall Street analysts, 6 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $185.00.
How accurate are MASI stock price projections?
Stock price projections, including those for Masimo Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 9, 2025 1:54 PM UTC